生物製程支援服務市場規模、佔有率和成長分析：按服務類型、生物製程類型、分子類型、最終用戶和地區分類－產業預測（2026-2033 年）

2024 年全球生物製程支援服務市場價值為 184.5 億美元，預計到 2025 年將成長至 207.2 億美元，到 2033 年將成長至 524.2 億美元，在預測期（2026-2033 年）內複合年成長率為 12.3%。

生物製程支援服務市場正經歷強勁成長，這主要得益於衛生監管機構對品質保證和驗證數據日益嚴格的監管要求。這些壓力促使製藥公司尋求外部專業知識，以簡化合規流程並加快產品核可，從而增加了與專業服務供應商的合作。該市場正從一個小眾領域發展成為一個涵蓋關鍵外包服務的綜合生態系統，例如細胞株開發、製程最佳化和分析測試——這些對於高效擴大生物製藥生產規模至關重要。對複雜生物製藥日益成長的需求需要許多公司無法企及的專業知識。這種情況持續為服務供應商帶來盈利的機遇，並保持著市場成長勢頭，尤其是在對合規性和創新監測解決方案日益重視的情況下。

全球生物程序支援服務市場的成長要素

生物製藥療法在藥物研發中的日益普及，顯著提升了對專業生物製程支援服務的需求。為了滿足產品品質和監管標準，製造商在放大生產、純化和驗證等環節尋求專家協助，服務供應商也因此不斷創造機會，提供客製化解決方案、整合先進技術並共用關鍵知識。這不僅縮短了研發週期，也降低了營運風險。此外，這些趨勢促進了生物技術公司與服務專家之間的合作，加速了製程改進，並支持了新療法的推出，最終強化了對貫穿產品整個生命週期的全面支持的需求。

限制全球生物程序支援服務市場的因素

複雜且不斷變化的法律規範對生物製程專案構成重大挑戰，要求詳盡的文件記錄、驗證和合規性標準。這迫使製造商投入大量資源以滿足嚴格的法規要求，往往導致專案延期和營運成本增加。在這種情況下，企業可能更傾向於選擇擁有成熟經驗和良好業績記錄的供應商，從而降低其使用外部支援服務的意願。因此，企業可能會推遲外包決策，直到監管環境更加明朗，這可能導致對支援服務的需求下降，並限制整個產業的整體成長潛力。

全球生物程序支援服務市場趨勢

全球生物製程支援服務市場正經歷顯著成長，這主要得益於先進的一次性系統作為傳統不銹鋼反應器的替代方案而迅速普及。這種轉變主要歸功於其帶來的諸多優勢，例如縮短週轉時間、降低污染風險以及提高驗證流程的效率。隨著生物製藥企業採用這些一次性平台，對能夠提供系統設計、合格和放大專業知識的專業支援服務的需求日益成長。具備材料相容性、供應鏈物流和成本效益型生命週期管理知識的供應商正成為企業的重要合作夥伴，幫助他們最佳化開發平臺，同時保持跨國際市場的營運柔軟性。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 一手數據和二手數據的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 行業概覽
• 競爭環境概述

市場動態與展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

主要市場因素

• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球生物程序支援服務市場規模：按服務類型分類

• 製程開發支援
• 分析支援服務
• 製造支援服務
• 驗證和品質服務

全球生物程序支援服務市場規模：依生物製程類型分類

• 上游生物程序
• 下游生物程序

全球生物製程支援服務市場規模：依分子類型分類

• 單株抗體
• 疫苗
• 細胞和基因治療
• 重組蛋白

全球生物程序支援服務市場規模：依最終用戶分類

• 生物製藥公司
• 合約研發生產組織（CDMO）
• 研究機構

全球生物程序支援服務市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Sartorius AG
• Lonza Group AG
• WuXi AppTec Co., Ltd.
• Catalent, Inc.
• Samsung Biologics Co., Ltd.
• FUJIFILM Holdings Corporation
• AGC Inc.
• Charles River Laboratories International, Inc.
• Repligen Corporation
• Bio-Techne Corporation
• Avantor, Inc.
• Asahi Kasei Corporation
• Getinge AB
• Eppendorf SE
• Abzena plc
• Recipharm AB
• KBI Biopharma, Inc.

結論與建議

Global Bioprocessing Support Services Market size was valued at USD 18.45 Billion in 2024 and is poised to grow from USD 20.72 Billion in 2025 to USD 52.42 Billion by 2033, growing at a CAGR of 12.3% during the forecast period (2026-2033).

The bioprocessing support services market is experiencing robust growth driven by increasing regulatory demands for quality assurance and validation data from health agencies. This pressure compels pharmaceutical companies to seek external expertise to streamline compliance and expedite product approvals, fostering partnerships with specialized service providers. The market has evolved from a niche segment into a comprehensive ecosystem encompassing outsourced services such as cell line development, process optimization, and analytical testing, all crucial for the efficient scaling of biologics manufacturing. The heightened demand for complex biologics necessitates specialized knowledge that surpasses the capabilities of many firms. This landscape continues to offer lucrative opportunities for service providers, especially as the emphasis on compliance and innovative monitoring solutions grows, sustaining market momentum.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioprocessing Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioprocessing Support Services Market Segments Analysis

Global bioprocessing support services market is segmented by service type, bioprocess type, molecule type, end user and region. Based on service type, the market is segmented into process development support, analytical support services, manufacturing support services and validation & quality services. Based on bioprocess type, the market is segmented into upstream bioprocessing and downstream bioprocessing. Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, cell & gene therapies and recombinant proteins. Based on end user, the market is segmented into biopharmaceutical companies, contract development & manufacturing organizations and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioprocessing Support Services Market

The increasing prevalence of biologic therapies in pharmaceutical development is significantly propelling the demand for specialized bioprocessing support services. As manufacturers look for expert assistance in areas such as scale-up, purification, and validation to meet product quality and regulatory standards, there arise consistent opportunities for service providers to deliver tailored solutions, integrate advanced technologies, and share essential knowledge. This not only expedites development timelines but also mitigates operational risks. Additionally, such trends promote collaborations between biotechnology companies and service specialists, enhancing process improvements and supporting the introduction of new therapies, ultimately strengthening the demand for comprehensive support across the entire product lifecycle.

Restraints in the Global Bioprocessing Support Services Market

The complex and ever-changing regulatory framework presents considerable challenges, requiring thorough documentation, validation, and adherence to compliance standards in bioprocessing endeavors. This necessity compels manufacturers to invest substantial resources to satisfy stringent regulations, often resulting in delayed project timelines and heightened operational expenses. Such conditions can hinder the willingness to embrace external support services, as companies favor providers with demonstrated expertise and solid track records. Consequently, businesses may postpone their outsourcing decisions until there is greater regulatory certainty, which can diminish the demand for support services and restrict overall growth potential within the industry.

Market Trends of the Global Bioprocessing Support Services Market

The Global Bioprocessing Support Services market is experiencing significant growth driven by the rapid adoption of advanced single-use systems over traditional stainless-steel bioreactors. This shift is largely attributed to the associated advantages such as shorter turnaround times, reduced contamination risks, and streamlined validation processes. As biopharmaceutical manufacturers embrace these disposable platforms, there is an increasing demand for specialized support services that offer expertise in designing, qualifying, and scaling these systems. Providers equipped with knowledge in material compatibility, supply chain logistics, and cost-effective lifecycle management are becoming crucial partners, empowering firms to enhance their development pipelines while maintaining operational flexibility across international markets.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Bioprocessing Support Services Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Process Development Support
• Analytical Support Services
• Manufacturing Support Services
• Validation & Quality Services

Global Bioprocessing Support Services Market Size by Bioprocess Type & CAGR (2026-2033)

• Market Overview
• Upstream Bioprocessing
• Downstream Bioprocessing

Global Bioprocessing Support Services Market Size by Molecule Type & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
• Vaccines
• Cell & Gene Therapies
• Recombinant Proteins

Global Bioprocessing Support Services Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Companies
• Contract Development & Manufacturing Organizations
• Research Institutes

Global Bioprocessing Support Services Market Size & CAGR (2026-2033)

• North America (Service Type, Bioprocess Type, Molecule Type, End User)
  • US
  • Canada
• Europe (Service Type, Bioprocess Type, Molecule Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Bioprocess Type, Molecule Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Bioprocess Type, Molecule Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Bioprocess Type, Molecule Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AGC Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abzena plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KBI Biopharma, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations